Details of the Drug

General Information of Drug (ID: DM8OYZB)

Drug Name
Imepitoin
Synonyms ADD-233089; AWD-131-138
Indication
Disease Entry ICD 11 Status REF
Convulsion 8A68.Z Discontinued in Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 279.72
Logarithm of the Partition Coefficient (xlogp) 1.2
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C13H14ClN3O2
IUPAC Name
3-(4-chlorophenyl)-5-morpholin-4-yl-4H-imidazol-2-one
Canonical SMILES
C1COCCN1C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl
InChI
InChI=1S/C13H14ClN3O2/c14-10-1-3-11(4-2-10)17-9-12(15-13(17)18)16-5-7-19-8-6-16/h1-4H,5-9H2
InChIKey
IQHYCZKIFIHTAI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
3083511
CAS Number
188116-07-6
TTD ID
D06BYS

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Translocator protein (TSPO) TTPTXIN TSPO_HUMAN Agonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008368)
2 The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy. CNS Drugs. 2014 Jan;28(1):29-43.